Press Releases
January 8, 2020
NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer
December 19, 2019
Neximmune Receives IND Clearance for Phase 1/2 Trial in Relapsed / Refractory Multiple Myeloma
December 2, 2019
NexImmune Management to Present at Upcoming Conferences
October 30, 2019
NexImmune Receives IND Clearance for Phase 1/2 trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome
September 19, 2019
NexImmune and the Multiple Myeloma Research Foundation (MMRF) discuss collaborative opportunities to advance promising new therapies
June 4, 2019
NexImmune Management Presents at the Jefferies Healthcare Conference
April 29, 2019
Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials
April 5, 2019
NexImmune Management to Present at Upcoming Conferences
December 11, 2018
NexImmune Granted Key US Patent for Core E+E Technology
December 4, 2018
NexImmune Completes Sr. Leadership Team with New VP Hires
Displaying 61 - 70 of 73